450
Participants
Start Date
November 1, 2020
Primary Completion Date
November 1, 2023
Study Completion Date
December 1, 2024
Units of transfusion
Participants will either receive 1-unit or 2-unit red blood cell outpatient transfusions
Lead Sponsor
Ottawa Hospital Research Institute
OTHER